Replies to post #23441 on RespireRx Pharmaceuticals Inc (RSPI)

[horselover45]

Eternal optimist that I am.

Looking at the last published drug pipeline CX1739 only shows about 1/3 of the way through phase one.
We have been allowed to go ahead and use it in phase two.
Using that thought my curiousity is aroused as to how far along on the preclinical chart are CX1942,CX1796 and the highend CX1837??
Hopefully my question will be answered this afternoon.

Andy C.